Literature DB >> 8264822

[Ultrasonographic study of the palpable breast tumor is very useful].

C I Perre1, P de Hooge, P A Hustinx, J W Muller.   

Abstract

OBJECTIVE: To determine the value of ultrasonographic examination in the assessment of palpable breast tumours, with special reference to the distinction between benign and malignant tumours.
DESIGN: Prospective ultrasonographic study; the results of the ultrasonographic examination were compared retrospectively with those of mammographic examination.
SETTING: Diakonessenhuis, Utrecht.
METHOD: In 282 successive patients, 300 palpable breast tumours were examined ultrasonographically in the period from December 1989 to May 1992 and the findings were compared with those of morbid-anatomical examination (histological examination in solid tumours, cytological examination in cysts). The results of ultrasonographic and mammographic examination of 241 tumours were compared.
RESULTS: Of the 300 palpable tumours examined ultrasonographically, 297 were included in the study (122 carcinomas and 175 benign lesions). The sensitivity of ultrasonography was 97.5%, its specificity 92.6%. The predictive value of a positive test result was 90.2%. When the results of ultrasonography and mammography were compared for 204 tumours, the sensitivity of ultrasonography proved to be 97.4% and its specificity 91.0%; for mammography, these figures were 91.3% and 75.3%, respectively.
CONCLUSION: Ultrasonography of palpable breast tumours can be a highly reliable diagnostic method, particularly with a view to distinguishing between malignant and benign lesions.

Entities:  

Mesh:

Year:  1993        PMID: 8264822

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  1 in total

1.  A cost-effective handheld breast scanner for use in low-resource environments: a validation study.

Authors:  Robyn B Broach; Rula Geha; Brian S Englander; Lucy DeLaCruz; Holly Thrash; Ari D Brooks
Journal:  World J Surg Oncol       Date:  2016-10-28       Impact factor: 2.754

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.